Vulnological versatility and effectiveness of Ozoile at the AIUC National Congress 2019

Ozoile in the treatment of venous ulcers in the lower limbs

Ozoile in new evidence, guidelines and strategies of the most common ENT diseases

Self-management with Ozoile and Dry Brushing in the patient with lymphedema

Ozoile in the treatment and prevention of injuries

Ozoile & Dry Brushing: a new self-management proposal for the patient with lymphedema

Rigenoma line with OZOILE for the wound care

La Erbagil Srl Growth Leader 2021 by "Il Sole 24 Ore" and "Statista"

Osservatorio Medico Scientifico

Erbagil is “Campione della crescita 2022”!

The 4th edition of the research, curated by the German Institute for Quality and Finance and la Repubblica, which examines the growth in turnover in the 2017-2020 three-year period of over 25,000 Italian companies, led Erbagil to reach position No. 133 in Italy. ? A special recognition that aims to give credit to companies considered excellence in the Italian economy, engines of growth despite the complex macroeconomic situation of recent years. A goal that makes us believe even more in our means and pushes us to always go beyond our expectations.

Erbagil Srl Growth Leader 2022 by "Il Sole 24 Ore" and "Statista"

FT 1000 2022, Erbagil among the best 1000 companies in Europe!

FT 1000 2022, ERBAGIL enters the Financial Times ranking.